Teva Pharmaceuticals USA: Valsartan Tablets, USP 320 mg, 90-count bottle,
Recall reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.. Recalled by Teva Pharmaceuticals USA. Distribution: Product was distributed throughout the United States, including Hawaii and Puerto Rico. Classification (Class II — potential health risk). Affected lots/NDC/dates: NDC 0591-2170-19 Lot Numbers: 1208002A, 1247282M, 1263944M NDC 0591-2170-05 Lot Numbers: 1208000M, 1208001M, 12404. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report